Incyte (INCY) Change in Accrued Expenses (2009 - 2026)
Incyte (INCY) reported Change in Accrued Expenses of $128.74 million for Q3 2026, up 11.8% from $115.14 million a year earlier.
Powered by 
Analysis
Incyte (INCY) Change in Accrued Expenses (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Incyte's Change in Accrued Expenses came in at -$21.77 million; for FY2025, it was -$148.2 million.
- By year, Change in Accrued Expenses came in at $278.94 million in FY2024 (+21.0%), $230.61 million in FY2023 (+4.7%), $220.2 million in FY2022 (+67.5%) and $131.44 million in FY2021 (+15.5%).
- Five-year quarterly Change in Accrued Expenses spans a low of -$476.73 million in Q2 2025 and a high of $138.55 million in Q4 2025.
- Year over year, Change in Accrued Expenses gained in three of the last five quarters, with an average decline of 0.8%.
- The high point for year-over-year Change in Accrued Expenses in five years was Q3 2024 (growth of 456.1%); the low point was Q3 2023 (a decline of 81.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at -$204.33 million (Q2 2026), -$84.73 million (Q1 2026) and $138.55 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | 128.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 128.74 Mn |
| Jun 30, 2026 | -204.33 Mn |
| Mar 31, 2026 | -84.73 Mn |
| Dec 31, 2025 | 138.55 Mn |
| Sep 30, 2025 | 115.14 Mn |
| Jun 30, 2025 | -476.73 Mn |
| Mar 31, 2025 | 74.84 Mn |
| Dec 31, 2024 | 129.77 Mn |
| Sep 30, 2024 | 121.74 Mn |
| Jun 30, 2024 | -78.04 Mn |
| Mar 31, 2024 | 105.47 Mn |
| Dec 31, 2023 | 116.22 Mn |
| Sep 30, 2023 | 21.89 Mn |
| Jun 30, 2023 | 20.60 Mn |
| Mar 31, 2023 | 71.90 Mn |
| Dec 31, 2022 | 47.81 Mn |
| Sep 30, 2022 | 120.73 Mn |
| Jun 30, 2022 | -2.14 Mn |
| Mar 31, 2022 | 53.79 Mn |
| Dec 31, 2021 | 46.40 Mn |
API Access
Incyte Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();